Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Joaquín Montalar Salcedo"'
Autor:
Joaquín Montalar Salcedo, Fernando Caballero Martínez, Ramon De Las Penas, Javier Cassinello Espinosa, Ana Blasco Cordellat, Yolanda Escobar Álvarez
Publikováno v:
Open Journal of Pain Medicine. :024-033
Background: The management of Breakthrough cancer Pain (BTcP) remains unsatisfactory. Although many barriers to BTcP management have been identified, oncologists have not been able to overcome them. The aim of this study is to identify the barriers p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21985cd58a4e4be8ca7e76e78464858b
https://doi.org/10.17352/ojpm.000020
https://doi.org/10.17352/ojpm.000020
Publikováno v:
Clinical and Translational Oncology. 12:92-99
Non-small-cell lung cancer (NSCLC) ranks among the neoplasms with the worst prognoses and the highest mortality rates. Several factors, mainly clinical, are known that provide a predictive value on the course of the disease. In the era in which we li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb35911c00daf3bb404304c79e542ba0
https://doi.org/10.1007/s12094-010-0475-y
https://doi.org/10.1007/s12094-010-0475-y
Autor:
Carmen Guillén Ponce, Joaquín Montalar Salcedo, Eva Barragán González, Eduardo Martínez de Dueñas, Eva Esteban Cardeñosa, Inmaculada de Juan Jiménez, Ángel Segura Huerta, Victoria Castel Sánchez, Sarai Palanca Suela, Isabel Chirivella González, Pascual Bolufer Gilabert
Publikováno v:
Breast Cancer Research and Treatment. 119:87-93
The polymorphic genetic differences among individuals may modify the high risk for breast cancer (BC) and/or ovarian cancer (OC) susceptibility conferred by BRCA1 and BRCA2 mutations. In the present study we investigate the relevance of RAD51 −135C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0bee1995fbb2d2029021e1539a94e0c
https://doi.org/10.1007/s10549-009-0316-2
https://doi.org/10.1007/s10549-009-0316-2
Autor:
Óscar Mauricio Niño Gómez, Koen Jerusalem, Miguel Pastor Borgoñón, Carmen Salvador Coloma, Encarnación Reche Santos, Joaquín Montalar Salcedo
Publikováno v:
Journal of NasoPharyngeal Carcinoma. 2
Introduction and objective: Nasopharyngeal carcinomas differ from other head and neck tumors. Patients have a higher rate of survival and thereby have a higher chance of presenting late toxicity, affecting their quality of life. We have tried to eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23def2565a49c162fc4a74226fbb43af
https://doi.org/10.15383/jnpc.26
https://doi.org/10.15383/jnpc.26
Autor:
Joaquín Montalar Salcedo, José Ponce Lorenzo, Ángel Guerrero Zotano, Lorena Pellín Ariño, Ángel Segura Huerta, Jorge Molina Saera, Laura Palomar Abad
Publikováno v:
Clinical and Translational Oncology. 7:55-59
Los carcinomas microciticos extrapulmonares (CMEP) se han reconocido como entidad diferenciada del carcinoma microcitico broncopulmonar (CMBP). Se consideran una enfermedad sistemica desde el inicio y esto hace que su abordaje sea similar al de los C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee33fbdcc7fd6095a2cce7d3947a8073
https://doi.org/10.1007/bf02710010
https://doi.org/10.1007/bf02710010
Autor:
Jorge Molina Saera, Lorena Pellín Ariño, Roberto Díaz Beveridge, Joaquín Montalar Salcedo, Ángel Segura Huerta, Jorge Aparicio Urtasun, Pedro López Tendero, Laura Palomar Abad, Ángel Guerrero Zotano
Publikováno v:
Clinical and Translational Oncology. 6:483-487
Introduction. Despite significant advances in the palliative care of cancer patients with terminal disease, a considerable proportion of them still die at hospital. The causes of this fact are multiple including sociocultural, familial, and sanitary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23eaf03ecbe6019cebbf4a4a1ee3da55
https://doi.org/10.1007/bf02713085
https://doi.org/10.1007/bf02713085
Autor:
María Fonfría Esparcia, Ángel Segura Huerta, Joaquín Montalar Salcedo, David Lorente Estellés, Gema Bruixola Campos, Javier Caballero Daroqui, Alejandra Giménez Ortiz, Esteban Rodrigo Imedio, Roberto Díaz Beveridge, Jorge Aparicio Urtasun
Publikováno v:
Medical Oncology. 31
Sorafenib is the standard treatment of patients with advanced hepatocellular carcinoma (HCC), with demonstrated outcome benefits in randomized clinical trials. We present a single-center experience with sorafenib with the aim to establish its efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8de1eca48d504e65f474efc090b6cad5
https://doi.org/10.1007/s12032-014-0948-x
https://doi.org/10.1007/s12032-014-0948-x
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 12(3)
Heat shock proteins are ubiquitous molecular chaperones involved in posttranslational folding, stability, activation and maturation of many proteins that are essential mediators of signal transduction and cell cycle progression. Hsp90 proteins are th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d9de74cd808031c4e482b85c51ae219
https://pubmed.ncbi.nlm.nih.gov/20231121
https://pubmed.ncbi.nlm.nih.gov/20231121
Autor:
Joaquín Montalar Salcedo, Laura Palomar Abad, José Ponce Lorenzo, Roberto Díaz Beveridge, Alejandra Giménez Ortiz, Jorge Molina Saera, Jorge Aparicio Urtasun
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 8(8)
Recent studies have suggested a rise in the incidence of testicular germ-cell tumors (TGTs) in the last years, mainly due to an increase of early stage cases. We analysed the time trends in biological features of these patients in order to confirm th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e010fd1c32dfe7f8fea334c02ddbca7
https://pubmed.ncbi.nlm.nih.gov/16952847
https://pubmed.ncbi.nlm.nih.gov/16952847
Autor:
Angel, Guerrero Zotano, Angel, Segura Huerta, Lorena, Pellín Ariño, Laura, Palomar Abad, Jorge, Molina Saera, José, Ponce Lorenzo, Joaquín, Montalar Salcedo
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 7(2)
Extra-pulmonary small cell carcinoma (ESCC) is as a pathologic entity distinct from small cell lung carcinoma (SCLC). ESCC is considered a systemic disease in its origin, so the therapeutic approach is similar to SCLC with chemotherapy being consider
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ce16a5076cf02dd298b23453edcdc094
https://pubmed.ncbi.nlm.nih.gov/15899209
https://pubmed.ncbi.nlm.nih.gov/15899209